Company & Sponsor Intelligence

Amsterdam UMC, location VUmc

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials5

Recruiting0

Completed2

Countries1

Therapeutic footprint

adhdalzheimersepilepsyparkinsons

Indexed studies

NCT06202872Memory Enhancement Using Transcranial Alternating Current Stimulation
alzheimers · NetherlandsNA

NCT05290311Long-Term Effects of CBT on Quality of Life in Adults With ADHD
adhd · NetherlandsCOMPLETED

NCT02473562Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease
parkinsons · NetherlandsPHASE4

NCT00454935Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
epilepsy · NetherlandsUNKNOWN

NCT01856738Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease
parkinsons · NetherlandsPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →